tirzepatide우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42551699
Safety and efficacy of glucagon like peptide-1 receptor agonism-based therapies in end-stage renal disease: A systematic review and meta-analysis.
Safety and efficacy of glucagon like peptide-1 receptor agonism-based therapies in end-stage renal disease: A systematic review and meta-analysis.
- 저자
- Deep Dutta, Sweekruti Jena, Kunal Mahajan, A B M Kamrul-Hasan, Saptarshi Bhattacharya, Ritin Mohindra
- 저널
- Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
- 공개일
- 2026 Aug 04
- 연구 유형
- 기타
- DOI
- 10.1016/j.eprac.2026.07.018
문헌 요약
No systematic review and meta-analysis (SRM) has analyzed the safety and efficacy of glucagon like peptide-1 receptor agonism-based therapies (GLP1RA-BT) in people with end stage renal disease (ESRD) [GFR<15ml/min/1.73m 2 or on renal replacement therapy (RRT)]. Hence this SRM analyzed the safety and efficacy of GLP1RA-BT in ESRD. Electronic databases were…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.